HIV Infection in Portugal: Measuring the Time Between Linkage to Care and Antiretroviral Therapy Initiation
Authors:
- Ana VirgolinoAVAna Virgolino
- Carolina FerrazCFCarolina Ferraz
- Vanessa NicolauVNVanessa Nicolau
- Rui CortesRCRui Cortes
- Aida PereiraAPAida Pereira
- Fernando MaltezFMFernando Maltez
- João Paulo CaldasJCJoão Paulo Caldas
- João LourinhoJLJoão Lourinho
- Maria AlvesMAMaria Alves
- Inês CaetanoICInês Caetano
- Tiago TeixeiraTTTiago Teixeira
- Isabel CasellaICIsabel Casella
Open Access
- 25 July 2025
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 13 (15) , 1812
Abstract
Background/Objectives: The timely initiation of antiretroviral therapy (ART) in persons living with HIV (PLWH) can improve clinical outcomes. However, ART commencement is often delayed. Portugal, despite having one of the highest new HIV diagnosis rates within the European Union, has limited available national-level data. Prior evidence from 2017 to 2018 suggests that the average time to ART initiation exceeds the recommendations for optimal patient benefits. This study aimed to determine the number of days from the first hospital appointment to the commencement of ART among newly diagnosed PLWH in Portugal between 2017 and 2022 at the national level and across different hospitals. It was hypothesized that newly diagnosed PLWH in Portugal experience a delay in ART initiation beyond the recommended timeframe. Methods: A retrospective analysis of records from Portuguese public tertiary care hospitals, which manage most HIV patients, was conducted. Descriptive statistics (measures of central tendency, dispersion, and frequency) were applied, along with association tests and a binary logistic regression model to examine factors influencing the timing of ART initiation. Results: A total of 2229 cases (out of 3434 received) from 19 hospitals were considered eligible. The median time interval between the first hospital appointment and ART initiation was 29.00 days, with a decreasing tendency between 2017 and 2022. Patients initiating therapy after 14 days had higher CD4 levels and lower viral loads compared to those starting within 14 days, with statistical significance. Conclusions: Continuous and regular monitoring of key indicators, such as the time to ART initiation, is pivotal for assessing the effectiveness of HIV treatment programs and pinpointing areas in need of improvement.Keywords
All Related Versions
Funding Information
- Gilead Sciences Lda
- Fundação para a Ciência e a Tecnologia (UID 04295—Instituto de Saúde Ambiental)
This publication has 42 references indexed in Scilit:
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in AdultsJAMA, 2023
- Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie StudyCurrent HIV/AIDS Reports, 2020
- Decreasing time to antiretroviral therapy initiation after HIV diagnosis in a clinic‐based observational cohort study in four African countriesJournal of the International AIDS Society, 2020
- ART in Prevention of Mother-to-Child Transmission of HIVThe Journal of Obstetrics and Gynecology of India, 2019
- Rapid initiation of antiretroviral therapy for people living with HIVCochrane Database of Systematic Reviews, 2019
- Providing antiretroviral therapy to all who are HIV positive: the clinical, public health and programmatic benefits of Treat AllJournal of the International AIDS Society, 2018
- Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trialThe Lancet HIV, 2018
- Four Types of Barriers to Adherence of Antiretroviral Therapy are Associated with Decreased Adherence Over TimeAIDS and Behavior, 2014
- When to Start ART in the Setting of Acute AIDS-Related Opportunistic Infections: The Time Is Now!Current HIV/AIDS Reports, 2012
- Recombination in AIDS virusesJournal of Molecular Evolution, 1995